Eurand v. Anchen Pharmaceuticals

U.S. Court of Appeals for the Federal Circuit

Eurand v. Anchen Pharmaceuticals

Opinion

NOTE: This order is nonprecedential.

Wniteb ~tate~ <!Court of §ppeaI~ for !be jfeberaI <!Circuit

IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT LITIGATION

EURAND, INC., CEPHALON, INC., AND ANESTA AG, Plaintiffs·Appellants,

v. ANCHEN PHARMACEUTICALS, INC•. AND ANCHEN, INC. Defendants-Appellees.

2011-1408, -1410, -1411, -1412

Appeals from the United States District Court for the District of Delaware in case no. 09-MD-2118, Judge Sue L. Robinson.

ON MOTION

ORDER The appellants move for a 30-day extension of time, until August 31, 2011, to file their opening brief. EURAND v. ANCHEN PHARMA 2

The court notes that a motion to dismiss these ap- peals was filed on July 25, 2011. Pursuant to Federal Circuit Rule 31(c), the briefing schedule is stayed.

Upon consideration thereof,

IT Is ORDERED THAT:

The motion is moot.

FOR THE COURT

JUL 262011 lsI Jan Horbaly Date Jan Horbaly Clerk cc: William J. Marsden, Jr., Esq. Donald J. Mizerk, Esq. s21 FILED U.s. COURT OF APPEALS FOR THE FEDERAL CIRCUIT

JUL 25 2011 JAN IWR8AI.Y CLERK

Reference

Status
Unpublished